BTLA mediates inhibition of human tumor-specific CD8+ T cells that can be partially reversed by vaccination.
作者:
主题词
动物(Animals);抗原, CD(Antigens, CD);抗原, 肿瘤(Antigens, Neoplasm);凋亡调节蛋白质类(Apoptosis Regulatory Proteins);CD8阳性T淋巴细胞(CD8-Positive T-Lymphocytes);COS细胞(COS Cells);细胞系, 肿瘤(Cell Line, Tumor);人类(Humans);干扰素γ(Interferon-gamma);淋巴细胞活化(Lymphocyte Activation);MART-1抗原(MART-1 Antigen);黑色素瘤(Melanoma);肿瘤蛋白质类(Neoplasm Proteins);寡脱氧核糖核苷酸类(Oligodeoxyribonucleotides);受体, 免疫(Receptors, Immunologic);受体, 肿瘤坏死因子, 成员14(Receptors, Tumor Necrosis Factor, Member 14);接种(Vaccination)
DOI
10.1172/JCI40070
PMID
20038811
发布时间
2021-10-20
- 浏览18
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文